Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase I Clinical and Pharmacokinetic Study of 1-(2-Chloroethyl)-3-sarcosinamide-1-nitrosourea in Patients with Refractory Solid Tumors

Phase I Clinical and Pharmacokinetic Study of 1-(2-Chloroethyl)-3-sarcosinamide-1-nitrosourea in Patients with Refractory Solid Tumors. ASCO. 2002; 78b (#2123).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.